Advertisement
Logos iRiS
Logos iRiS

The Scientist

» biotechnology and developmental biology

Most Recent

image: Tuning the Brain

Tuning the Brain

By | October 28, 2013

Deep-brain stimulation is allowing neurosurgeons to adjust the neural activity in specific brain regions to treat thousands of patients with myriad neurological disorders.

3 Comments

image: DARPA Supports Brain Treatment

DARPA Supports Brain Treatment

By | October 28, 2013

Brain-implant technologies just got a vote of government confidence, as the Defense Advanced Research Projects Agency announces an investment of $70 million over five years.

1 Comment

image: About Face

About Face

By | October 25, 2013

Researchers show that genetic enhancer elements likely contribute to face shape in mice.

0 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Venter’s New Digs

Venter’s New Digs

By | October 9, 2013

Genomics pioneer Craig Venter is building a new campus for his non-profit research institute right next to his alma mater in San Diego.

0 Comments

image: Building 3-D Microbial Communities

Building 3-D Microbial Communities

By | October 7, 2013

Researchers apply a 3-D printing technique to structure populations of bacteria in a three-dimensional environment.

0 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Remaking a Classic

Remaking a Classic

By | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

image: Week in Review: August 26–30

Week in Review: August 26–30

By | August 30, 2013

New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
Diagenode
Diagenode
Advertisement
LabX
LabX
RayBioTech